The UK is witnessing a significant shift in its attitude towards mind-altering substances. What began with a emerging exploration of ‘shrooms’ and classic ceremonial brews is increasingly expanding to encompass novel substances like copyright and potentially research into clinical uses. This developing interest is fuelled by growing promising e